A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Apraclonidine
Parnaparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Parnaparin.
Apraclonidine
Bemiparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bemiparin.
Apraclonidine
Dextran
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Dextran.
Apraclonidine
Sodium citrate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Sodium citrate.
Apraclonidine
Potassium citrate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Potassium citrate.
Apraclonidine
Edoxaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Edoxaban.
Apraclonidine
Vorapaxar
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Vorapaxar.
Apraclonidine
Ditazole
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Ditazole.
Apraclonidine
Ticagrelor
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Ticagrelor.
Apraclonidine
Triflusal
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Triflusal.
Apraclonidine
Nadroparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Nadroparin.
Apraclonidine
Ethyl biscoumacetate
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Ethyl biscoumacetate.
Apraclonidine
(R)-warfarin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with (R)-warfarin.
Apraclonidine
Ferulic acid
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Ferulic acid.
Apraclonidine
Tinzaparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tinzaparin.
Apraclonidine
Dalteparin
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Dalteparin.
Apraclonidine
Danaparoid
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Danaparoid.
Apraclonidine
Amediplase
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Amediplase.
Apraclonidine
Otamixaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Otamixaban.
Apraclonidine
Apixaban
The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Apixaban.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3